Celldex Therapeutics, Inc. - Common Stock (NQ:CLDX)
All News about Celldex Therapeutics, Inc. - Common Stock
Forecasting The Future: 6 Analyst Projections For Celldex Therapeutics ↗
February 28, 2025
Via Benzinga
Via GlobeNewswire
Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
December 19, 2024
Via GlobeNewswire
Celldex Therapeutics to Present at Upcoming Investor Conferences
November 11, 2024
Via GlobeNewswire